Mass Drug Administration Coverage Evaluation for Elimination of Lymphatic Filariasis in Nagpur District of Maharashtra

Jadhao, Dr Ashok Rupraoji

doi:10.18535/jmscr/v5i9.144

Cited by 4 publications

(10 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Few other recent studies across India revealed varied compliance of MDA ranging from 75.5% to 87.7%. [12131516] Coverage compliance gap (CCG), the proportion of people who did not consume the drug among whom drug was distributed, was 12.1% in present study; which is in line with that observed by Jadhao et al (12.23%)[12] and Kumar et al (12.2%)[19] in similar settings.…”

Section: Discussionsupporting

confidence: 91%

“…The present study revealed that distribution and consumption coverage among study population were 55.2% and 48.5% respectively, supervised consumption being 28.9%; which were much below than desired. Similar finding was obtained by Jadhao et al [12] in a recent community based study at Kamptee area of Nagpur city, where distribution and consumption coverage were 57.32% and 50.31% respectively. Parande et al observed coverage of MDA as low as 23% in slum areas of Solapur district of Mahatashtra.…”

Section: Discussionsupporting

confidence: 89%

See 1 more Smart Citation

Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study

Banerjee

Bandyopadhyay

Khan

et al. 2019

J Family Med Prim Care

View full text Add to dashboard Cite

Background and Aims:Mass Drug Administration (MDA) coverage remains an important indicator in elimination of Lymphatic Filariasis (LF), especially in context of recent changes in programme strategies in India, such as incorporation of Ivermectin and involvement of urban Accredited Social Health Activists (ASHAs). This study aimed at assessing the coverage and compliance with MDA of Filariasis as well as exploring perspective of beneficiaries for non-consumption in selected slum area of Nagpur city.Methods:Mixed-method study design comprising of quantitative assessment of MDA coverage, followed by qualitative method to explore the reasons of non-compliance was used in selected slum areas of Nagpur city. Using cluster sampling, 240 households were selected and house-to-house visits were made to interview the eligible participants. In-depth interviews were conducted among selected non-compliant participants.Statistical Analysis:Multivariable logistic regression analysis to identify the factors associated with non-consumption. Thematic analysis was done to obtain the reasons of non-consumption as perceived by the beneficiaries.Results:Among the 1096 individuals studied, distribution and consumption coverage were 55.2% and 48.5%, respectively. Effective supervised consumption was further low (28.9%). Coverage compliance gap (CCG) was 12.1%. Male sex and younger age (2-5 years) were significant socio-demographic determinants of non-consumption. No repeat visit to houses left in first round, fear of side effects, pill burden, poor understanding about the need were important reasons as revealed by qualitative inquiry.Conclusion:Effective pre-campaign awareness, incorporation of context specific drug delivery strategies and strengthening monitoring system are essential for successful MDA implementation.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionsupporting

confidence: 89%

Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study

Banerjee

Bandyopadhyay

Khan

et al. 2019

J Family Med Prim Care

View full text Add to dashboard Cite

show abstract

“…In the present study, multistage sampling technique adopted to select 3 rural clusters and one urban area. Similar techniques used in a study Dr Ashok Rupraoji Jadhao et al in Nagpur district of Maharastra (10) and Paul A et al in in Purbabarddhaman District, West Bengal (11) Sex wise distribution of our study was found to be 47.1 % for males and 52.9 % for females. The result is With regard to the age group of respondents, in our study 94.2 % of the respondents were in the age group 15-59 years.…”

Section: Discussionsupporting

confidence: 82%

“…The role of ASHA is significantly appreciable in rural areas (100%). Our finding is higher than the study result conducted by a Jadhao AR et al in Nagpur district of Maharashtra (86.4% obtained the information from various field level health workers) (10) and similarly another study conducted by Paul A et al shows, FLW were the most frequent (80.82%) source of knowledge sharing about MDA. (11) With regard to various forms of IEC material used, Posters and banners were found to be the effective forms of IEC material assisted in creating community awareness both in rural and urban Vizianagaram.…”

Section: Discussioncontrasting

confidence: 74%

Assessment of Mass Drug Administration activities for Lymphatic Filariasis Elimination in Vizianagaram District of Andhra Pradesh

2020

IJPHRD

View full text Add to dashboard Cite

Background: Lymphatic Filariasis commonly known as elephantiasis is a painful and profoundly disfiguring disease that has a major social and economic impact. Mass Drug Administration (MDA) programme for the elimination Lymphatic Filariasis (LF) has been implemented globally since 1997 and the MDA campaign launched in India during 2004 to interrupt the transmission of Lymphatic Filariasis Methods: The present study is a cross-sectional descriptive study conducted from 13 th to16 th June, 2019 in Vizianagaram district of Andhra Pradesh. The three rural and one urban area of Vizianagaram district were selected using multistage cluster sampling technique Clusters of 30 houses from one village of each PHC and one ward of urban area with a total of 120 households were selected for the study.Results: A total of 120 households covering 456 population were surveyed out of which 47.1% were male and rest 52.9 % were females. Overall drug distribution coverage is 94% and effective coverage rate is 88%. Conclusions:There is a pressing need to promote operational research on possible transmission from nearby districts and confirmatory mapping of uncertain areas. Further qualitative comprehensive studies with more diverse participants are needed to ascertain the causal relationship.

show abstract

“…(17) The study done by Jadhao et al reported most common reason for non-consumption was didn't receive the drugs followed by forgot to take drug. (18) The study done by Haldar et al reported most common reason for non-consumption was fear of side effects followed by not told specifically why to consume. (19) The study done by Kumar et al showed that 3 cases (0.59%) had adverse reactions, all are mild cases like giddiness, Vomiting and gastric irritation.…”

Section: Discussionmentioning

confidence: 99%

Coverage evaluation of Mass Drug Administration (MDA) for lymphatic filariasis in a district of Bundelkhand Region of Uttar Pradesh

Barman¹,

Kumar²,

Barman³

et al. 2022

Indian J Community Health

View full text Add to dashboard Cite

Introduction: Lymphatic filariasis results in severe disability that leading to severe social and economic burden at each level from individual to family, and community. This study was carried out to assess the coverage and compliance of MDA. Methods: From 300 households (1837 individuals) in both rural & urban area were covered in coverage evaluation survey by systematic selection of subunits using probability proportionate to size (PPS). Each household was visited by WHO designated team and data were collected using predesigned questionnaire. Data was compiled on MS-excel spreadsheet, frequency and percentage were calculated. Results: The overall effective coverage for all drugs was low (19.1%). The coverage was low, compliance was higher in urban as compared to rural area. Females had better coverage and compliance than males. The primary reasons for drug not offered was nobody came to offer drug, drug not swallowed was not sick, drug swallowed was useful information from drug administrator (DA). Only one female reported adverse effect. Conclusion: Increase in coverage along with decrease in coverage-compliance gap is needed to achieve filariasis elimination that warrants intense IEC activities using different platforms, development of better drug delivery strategies and strengthening monitoring system.

show abstract

Mass Drug Administration Coverage Evaluation for Elimination of Lymphatic Filariasis in Nagpur District of Maharashtra

Cited by 4 publications

References 5 publications

Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study

Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study

Assessment of Mass Drug Administration activities for Lymphatic Filariasis Elimination in Vizianagaram District of Andhra Pradesh

Coverage evaluation of Mass Drug Administration (MDA) for lymphatic filariasis in a district of Bundelkhand Region of Uttar Pradesh

Contact Info

Product

Resources

About